Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity
about
Endocrine causes of nonalcoholic fatty liver diseaseNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayObesity and Insulin Resistance Are the Central Issues in Prevention of and Care for Comorbidities.Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease.C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication.Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity.A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis.Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells.Ferroportin Expression in Adipocytes Does Not Contribute to Iron Homeostasis or Metabolic Responses to a High Calorie Diet.Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.
P2860
Q26780254-5077E47A-1CDC-4C36-A86F-80733EB54988Q26800894-27356B7C-9A7A-4333-A38B-61DC506A6AF2Q37081549-1F69BF1D-50B2-4755-8110-6B15F16A997CQ38734992-A9A13DB3-3DF4-4864-BA32-80BF618B11D5Q38808650-392A17D9-104C-4869-ABDF-E655C2EC17E8Q38964762-FAFCE030-8B61-47B0-9526-29159682E281Q49144853-75A77ED3-C616-459C-AC7B-5A00D243E9E0Q51361802-D02AD457-1BB1-418E-875C-03C99227418CQ52640242-23463170-1790-4C4E-AE6D-F631175893BCQ52758998-E8757999-9E77-45CA-83C7-9BEC8F5A38F7Q52931087-A214936B-99E7-4584-984C-1ACDE4063EA8Q54094756-CD84FCD0-EA2F-4571-8A68-CA92B79A98B0Q55379918-1B7EDE8E-2A1E-495B-BB5C-C0C44BD545FD
P2860
Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Determining the association be ...... fatty liver disease in obesity
@ast
Determining the association be ...... fatty liver disease in obesity
@en
type
label
Determining the association be ...... fatty liver disease in obesity
@ast
Determining the association be ...... fatty liver disease in obesity
@en
prefLabel
Determining the association be ...... fatty liver disease in obesity
@ast
Determining the association be ...... fatty liver disease in obesity
@en
P2093
P2860
P356
P1433
P1476
Determining the association be ...... fatty liver disease in obesity
@en
P2093
A Driessen
C Wijmenga
D P Y Koonen
F J Verdam
M G M Wolfs
M H Hofker
P2860
P2888
P356
10.1038/NUTD.2014.43
P577
2015-02-09T00:00:00Z
P5875
P6179
1020368195